SCO-094
Obesity, Diabetes
PreclinicalPartnered
Key Facts
About SCOHIA PHARMA
A Japanese bioventure developing innovative small molecule drugs for metabolic, cardiovascular, and renal diseases through a diversified pipeline and strategic collaborations.
View full company profileTherapeutic Areas
Other Obesity, Diabetes Drugs
| Drug | Company | Phase |
|---|---|---|
| Subcutaneous Zenagamtide | Novo Nordisk | Phase 2 |